Pancreatic Cancer

Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. De...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2010-04, Vol.362 (17), p.1605-1617
1. Verfasser: Hidalgo, Manuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1617
container_issue 17
container_start_page 1605
container_title The New England journal of medicine
container_volume 362
creator Hidalgo, Manuel
description Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease. 1 Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is
doi_str_mv 10.1056/NEJMra0901557
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733929451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733929451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</originalsourceid><addsrcrecordid>eNp10LtLA0EQBvBFFBOjhYWt2IjV6ezOPks54ov4KLRe9vbmICGXxN2kyH_vyUXBwmlmih8fzMfYGYdrDkrfvIyfnlMAB1wps8eGXCEWUoLeZ0MAYQtpHA7YUc4z6IZLd8gGAqQwFtyQnb6FRUwU1tN4UXYnpWN20IR5ppPdHrGPu_F7-VBMXu8fy9tJEVHrdWGtNTUXlkjJSJVCoYwV2hjDSUbESmMFjdXCigaaUIPi4BqDQkhUFdY4Yld97iotPzeU176d5kjzeVjQcpO9QXTCScU7WfQypmXOiRq_StM2pK3n4L9L8H9K6Pz5LnlTtVT_6p-vO3DZg7bNfkGz9p-gLzBuXx8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733929451</pqid></control><display><type>article</type><title>Pancreatic Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Hidalgo, Manuel</creator><creatorcontrib>Hidalgo, Manuel</creatorcontrib><description>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease. 1 Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is &lt;5%. 1 , 2 The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMra0901557</identifier><identifier>PMID: 20427809</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Antineoplastic Agents - therapeutic use ; Combined Modality Therapy ; Deoxycytidine - analogs &amp; derivatives ; Deoxycytidine - therapeutic use ; Humans ; Neoplasm Staging - methods ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - etiology ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - therapy ; Risk Factors ; Smoking - adverse effects</subject><ispartof>The New England journal of medicine, 2010-04, Vol.362 (17), p.1605-1617</ispartof><rights>Copyright © 2010 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</citedby><cites>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMra0901557$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMra0901557$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,780,784,2758,2759,26102,27923,27924,52381,54063,64386</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20427809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hidalgo, Manuel</creatorcontrib><title>Pancreatic Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease. 1 Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is &lt;5%. 1 , 2 The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Deoxycytidine - therapeutic use</subject><subject>Humans</subject><subject>Neoplasm Staging - methods</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - etiology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10LtLA0EQBvBFFBOjhYWt2IjV6ezOPks54ov4KLRe9vbmICGXxN2kyH_vyUXBwmlmih8fzMfYGYdrDkrfvIyfnlMAB1wps8eGXCEWUoLeZ0MAYQtpHA7YUc4z6IZLd8gGAqQwFtyQnb6FRUwU1tN4UXYnpWN20IR5ppPdHrGPu_F7-VBMXu8fy9tJEVHrdWGtNTUXlkjJSJVCoYwV2hjDSUbESmMFjdXCigaaUIPi4BqDQkhUFdY4Yld97iotPzeU176d5kjzeVjQcpO9QXTCScU7WfQypmXOiRq_StM2pK3n4L9L8H9K6Pz5LnlTtVT_6p-vO3DZg7bNfkGz9p-gLzBuXx8</recordid><startdate>20100429</startdate><enddate>20100429</enddate><creator>Hidalgo, Manuel</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100429</creationdate><title>Pancreatic Cancer</title><author>Hidalgo, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Deoxycytidine - therapeutic use</topic><topic>Humans</topic><topic>Neoplasm Staging - methods</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - etiology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hidalgo, Manuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hidalgo, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancreatic Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2010-04-29</date><risdate>2010</risdate><volume>362</volume><issue>17</issue><spage>1605</spage><epage>1617</epage><pages>1605-1617</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer. Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease. 1 Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is &lt;5%. 1 , 2 The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>20427809</pmid><doi>10.1056/NEJMra0901557</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2010-04, Vol.362 (17), p.1605-1617
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_733929451
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Antineoplastic Agents - therapeutic use
Combined Modality Therapy
Deoxycytidine - analogs & derivatives
Deoxycytidine - therapeutic use
Humans
Neoplasm Staging - methods
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - etiology
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - therapy
Risk Factors
Smoking - adverse effects
title Pancreatic Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancreatic%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Hidalgo,%20Manuel&rft.date=2010-04-29&rft.volume=362&rft.issue=17&rft.spage=1605&rft.epage=1617&rft.pages=1605-1617&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMra0901557&rft_dat=%3Cproquest_cross%3E733929451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733929451&rft_id=info:pmid/20427809&rfr_iscdi=true